Bizkaia strengthens its position as a hub for entrepreneurship and innovation95% of the startups come from outside Spain
De la Academia a la ConsultoríaEl Viaje Estratégico de Byung-Ik Jung como Anderson Consulting Partner
Empoderando a Innovadores Glocales a través de la Perspectiva Global y la Acción LocalLa visión del Decano Joon-Ki Han para Busan International College
Everus Construction Group, Inc. (ECG) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
INE Security Alert: $16.6 Billion in Cyber Losses Underscore Critical Need for Advanced Security Training
[Joon-Ki Han’s HR Insights]The Rise of the Employfluencer: How Employee Experience Shapes the Future of Work
Biopharma-Führungskräfte bringen die Zukunft der Biowissenschaften auf dem Veeva Commercial Summit Europe voran
St. Matthew’s Parish School Unveils Comprehensive Plans for Return to Pacific Palisades Campus in Fall 2026
VFC SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of V.F. Corporation
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
LFMD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
SMLR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research
Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026
UN Global Compact, African Union and Partners Convene 4th African Business and Human Rights Forum to Advance Remedy, Reparations and Responsible Business in Africa
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
